MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Country |
 USA |
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITALSPB |
Shares |
1.27 M |
Market Cap[1] |
$ 1.46 M |
EBITDA (LTM) |
$ -94.1 M |
P/E (LTM) |
-0.03 |
P/S (LTM) |
0.05 |
EPS (LTM) |
-35.65 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
$ 118.32 | -2.52 % | $ 36 B | NYSE,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Celcuity
CELC
|
$ 110.1 | -1.44 % | $ 4.34 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Charles River Laboratories International
CRL
|
$ 178.1 | -0.22 % | $ 8.83 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 28.14 | -4.84 % | $ 782 M | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 206.14 | -2.14 % | $ 147 B | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 10.99 | -8.19 % | $ 312 M | Nasdaq Capital Market |  Israel |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
DexCom
DXCM
|
$ 73.42 | -0.01 % | $ 28.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.42 | 0.04 % | $ 19.5 B | Nasdaq Capital Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Fulgent Genetics
FLGT
|
$ 14.29 | -6.78 % | $ 432 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 93.46 | -0.47 % | $ 11.7 B | Nasdaq Global Select Market,SPB | USA |
|
Biodesix
BDSX
|
$ 15.57 | 1.57 % | $ 2.02 B | Nasdaq Global Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 109.39 | 1.16 % | $ 9.02 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
$ 638.26 | -2.81 % | $ 51.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Illumina
ILMN
|
$ 133.12 | -1.0 % | $ 21.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
IQVIA Holdings
IQV
|
$ 174.81 | -2.21 % | $ 30 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 286.78 | -0.81 % | $ 23.9 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 76.54 | 2.17 % | $ 5.17 B | Nasdaq Global Select Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.71 | -0.8 % | $ 546 M | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 456.55 | 1.06 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 326.13 | -2.97 % | $ 27.3 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 5.01 | 8.79 % | $ 464 M | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
NeoGenomics
NEO
|
$ 9.51 | -3.31 % | $ 1.22 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 11.22 | -0.13 % | $ 2.43 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 18.85 | 0.48 % | $ 1 B | Nasdaq Global Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 3.83 | -7.65 % | $ 2.06 M | Nasdaq Global Select Market | USA |
 |
National Research Corporation
NRC
|
$ 14.09 | 5.03 % | $ 346 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 203.35 | -2.25 % | $ 20 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.24 | 3.33 % | $ 861 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.67 | -0.89 % | $ 501 M | Nasdaq Global Select Market,SPB | USA |
 |
Precipio
PRPO
|
$ 24.62 | 2.23 % | $ 32 M | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 9.16 | 1.1 % | $ 543 M | Nasdaq Global Select Market | USA |
 |
RadNet
RDNT
|
$ 74.81 | 7.16 % | $ 5.46 B | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.